Anfield Capital Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Anfield Capital Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$40,139
-22.8%
2,158
-47.1%
0.02%
-20.0%
Q3 2022$52,000
+85.7%
4,078
+2.4%
0.02%
+92.3%
Q2 2022$28,000
-6.7%
3,983
+10.5%
0.01%
+18.2%
Q1 2022$30,000
+172.7%
3,603
+126.2%
0.01%
+175.0%
Q4 2021$11,000
+1000.0%
1,593
+1174.4%
0.00%
Q3 2021$1,0001250.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders